Cart
sales@molnova.com
MYLS22
CAS No. 306959-01-3
MYLS22 ( —— )
Catalog No. M23118 CAS No. 306959-01-3
MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 51 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 149 | In Stock |
|
| 50MG | 228 | In Stock |
|
| 100MG | 352 | In Stock |
|
| 200MG | 528 | In Stock |
|
| 500MG | 836 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMYLS22
-
NoteResearch use only, not for human use.
-
Brief DescriptionMYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
-
DescriptionMYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number306959-01-3
-
Formula Weight443.5
-
Molecular FormulaC??H??N?O?S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL (112.73 mM; ultrasonic and warming and heat to 60°C)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stéphanie Herkenne, et al. Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020 May 5;31(5):987-1003.e8.
molnova catalog
related products
-
Ganosinensic acid C
The fruit body of Ganoderma sinense.
-
Luminol
Luminol(Diogenes reagent) is a versatile chemical, exhibits chemiluminescence, with a striking blue glow, when mixed with an appropriate oxidizing agent.
-
Temocapril HCl
Temocapril HCl, the hydrochloride of Temocapril, is a long-acting ACE inhibitor used for the therapy of hypertension.
